Back to search

Peptide record

TPDB15654

Antibacterial Anticancer Antifungal Toxicity modified_plain modified
14 source-reported length (unverified)
Basic Information
TPDB15654
Antibacterial Anticancer Antifungal Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
dbAMP Peptipedia CAFPdb
modified_plain
Yes
A modified multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide record curated from dbAMP, Peptipedia, and CAFPdb, without an available 3D structural model. Source-reported length: 14 (unverified).
Modified, details unspecified
Sequence
XRLFKKLLKYLRKX

Source notation is retained verbatim; residue notation and chemical identity have not been independently validated. The displayed length is source-reported and unverified.

Physicochemical Analysis

Sequence-only estimates are not provided for modified or non-standard source notation. Reported molecular properties, when available, are retained below with their source records.

Chemical Descriptors
14 source-reported length (unverified)
Evidence Records 6 records
Evidence 1 Activity

Activity

19.02±0.08% Hemolysis
Toxicity
32 µM
Hemolytic Cytotoxic
19.02±0.08% Hemolysis | 32 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
D- and Unnatural Amino Acid Substituted Antimicrobial Peptides With Improved Proteolytic Resistance and Their Proteolytic Degradation Characteristics. | Front Microbiol | 2020
Evidence 2 Activity

Activity

55.99±3.75% Hemolysis
Toxicity
64 µM
Hemolytic Cytotoxic
55.99±3.75% Hemolysis | 64 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
D- and Unnatural Amino Acid Substituted Antimicrobial Peptides With Improved Proteolytic Resistance and Their Proteolytic Degradation Characteristics. | Front Microbiol | 2020
Evidence 3 Activity

Activity

95.99±2.1% Hemolysis
Toxicity
128 µM
Hemolytic Cytotoxic
95.99±2.1% Hemolysis | 128 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
D- and Unnatural Amino Acid Substituted Antimicrobial Peptides With Improved Proteolytic Resistance and Their Proteolytic Degradation Characteristics. | Front Microbiol | 2020
Evidence 4 Activity

Activity

22.52±1.07% Hemolysis
Toxicity
32 µM
Hemolytic Cytotoxic
22.52±1.07% Hemolysis | 32 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
D- and Unnatural Amino Acid Substituted Antimicrobial Peptides With Improved Proteolytic Resistance and Their Proteolytic Degradation Characteristics. | Front Microbiol | 2020
Evidence 5 Activity

Activity

56.82±2.62% Hemolysis
Toxicity
64 µM
Hemolytic Cytotoxic
56.82±2.62% Hemolysis | 64 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
D- and Unnatural Amino Acid Substituted Antimicrobial Peptides With Improved Proteolytic Resistance and Their Proteolytic Degradation Characteristics. | Front Microbiol | 2020
Evidence 6 Activity

Activity

95.02±1.84% Hemolysis
Toxicity
128 µM
Hemolytic Cytotoxic
95.02±1.84% Hemolysis | 128 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
D- and Unnatural Amino Acid Substituted Antimicrobial Peptides With Improved Proteolytic Resistance and Their Proteolytic Degradation Characteristics. | Front Microbiol | 2020